FDA Approves Rapid-Acting Inhaled Insulin for Children

FRIDAY, June 12, 2026-- The U.S. Food and Drug Administration has approved Afrezza (insulin human) Inhalation Powder for use in children and adolescents aged 6 years and older who are living with type 1 or type 2 diabetes.Afrezza delivers insulin...